# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001564590-21-014020
Filing Date
2021-03-18
Accepted
2021-03-18 08:31:42
Documents
61
Period of Report
2021-03-18
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | agle-8k_20210318.htm iXBRL | 8-K | 44970
2 | EX-99.1 | agle-ex991_6.htm | EX-99.1 | 247282
3 | EX-99.2 | agle-ex992_123.htm | EX-99.2 | 55692
4 | GRAPHIC | slide-eovv43nrvlq.jpg | GRAPHIC | 66662
5 | GRAPHIC | slide-3hsbswr1gw2.jpg | GRAPHIC | 53715
6 | GRAPHIC | slide-badgnox0ksl.jpg | GRAPHIC | 53964
7 | GRAPHIC | slide-b34hjrr351d.jpg | GRAPHIC | 62125
8 | GRAPHIC | slide-y2upb5yyy4j.jpg | GRAPHIC | 19960
9 | GRAPHIC | slide-0prd4w5bmhz.jpg | GRAPHIC | 62546
10 | GRAPHIC | slide-tbgd1gbrsmj.jpg | GRAPHIC | 66008
11 | GRAPHIC | slide-e3ixgonjfwi.jpg | GRAPHIC | 53458
12 | GRAPHIC | slide-tqp21u204gq.jpg | GRAPHIC | 62784
13 | GRAPHIC | slide-kbfnl3t2j5a.jpg | GRAPHIC | 48883
14 | GRAPHIC | slide-2cnhrn3bzj3.jpg | GRAPHIC | 45717
15 | GRAPHIC | slide-u3jzxhiesff.jpg | GRAPHIC | 63473
16 | GRAPHIC | slide-qy5fefjp3iv.jpg | GRAPHIC | 16358
17 | GRAPHIC | slide-qzcghtjiqq4.jpg | GRAPHIC | 60918
18 | GRAPHIC | slide-v4q2u2f4zrx.jpg | GRAPHIC | 51316
19 | GRAPHIC | slide-jlqryz3cl03.jpg | GRAPHIC | 54248
20 | GRAPHIC | slide-dslyrqf3uxz.jpg | GRAPHIC | 36650
21 | GRAPHIC | slide-ec5mj4y1mob.jpg | GRAPHIC | 60605
22 | GRAPHIC | slide-ia1jlwxtmba.jpg | GRAPHIC | 48248
23 | GRAPHIC | slide-njiprv4m3xc.jpg | GRAPHIC | 56224
24 | GRAPHIC | slide-ajm3jzbbmmp.jpg | GRAPHIC | 32192
25 | GRAPHIC | slide-wwocxucrrqq.jpg | GRAPHIC | 52978
26 | GRAPHIC | slide-fq00dghx3re.jpg | GRAPHIC | 65238
27 | GRAPHIC | slide-hzpmqakbsuc.jpg | GRAPHIC | 76870
28 | GRAPHIC | slide-xjf4iz0gvn4.jpg | GRAPHIC | 67995
29 | GRAPHIC | slide-nzzbzv0i2d4.jpg | GRAPHIC | 18027
30 | GRAPHIC | slide-a0ayy1xex0b.jpg | GRAPHIC | 66335
31 | GRAPHIC | slide-yl04mqsseu4.jpg | GRAPHIC | 29146
32 | GRAPHIC | slide-jvy4vswliwh.jpg | GRAPHIC | 105159
33 | GRAPHIC | slide-mfryu4tvlqa.jpg | GRAPHIC | 56542
34 | GRAPHIC | slide-lyp3kb5hhjm.jpg | GRAPHIC | 57838
35 | GRAPHIC | slide-gouygecl2as.jpg | GRAPHIC | 66939
36 | GRAPHIC | slide-213kiqmlsom.jpg | GRAPHIC | 50213
37 | GRAPHIC | slide-feerk5fpkra.jpg | GRAPHIC | 49541
38 | GRAPHIC | slide-izsz2oc3p2p.jpg | GRAPHIC | 46781
39 | GRAPHIC | slide-wrk4fgoswzt.jpg | GRAPHIC | 51810
40 | GRAPHIC | slide-mo2q5dxrz0e.jpg | GRAPHIC | 42023
41 | GRAPHIC | slide-v3o1cyxivkq.jpg | GRAPHIC | 76167
42 | GRAPHIC | ghnj2ghmswlp000001.jpg | GRAPHIC | 9332
43 | GRAPHIC | slide-oyh1sk453qq.jpg | GRAPHIC | 43354
44 | GRAPHIC | slide-jr4tuhgw3fp.jpg | GRAPHIC | 52042
45 | GRAPHIC | slide-m3ktmcrtia3.jpg | GRAPHIC | 61202
46 | GRAPHIC | slide-cwzbioxl30b.jpg | GRAPHIC | 18143
47 | GRAPHIC | slide-zkwoimmv5mr.jpg | GRAPHIC | 56256
48 | GRAPHIC | slide-qjhshjtvmyq.jpg | GRAPHIC | 20506
49 | GRAPHIC | slide-azs1zqtjshz.jpg | GRAPHIC | 56760
50 | GRAPHIC | slide-4xxdn155u3m.jpg | GRAPHIC | 51611
| Complete submission text file | 0001564590-21-014020.txt |  | 3864317

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
51 | XBRL TAXONOMY EXTENSION SCHEMA | agle-20210318.xsd | EX-101.SCH | 5764
52 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | agle-20210318_lab.xml | EX-101.LAB | 20227
53 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | agle-20210318_pre.xml | EX-101.PRE | 12075
54 | EXTRACTED XBRL INSTANCE DOCUMENT | agle-8k_20210318_htm.xml | XML | 3689

Mailing Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746
Business Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37722 | Film No.: 21753179
SIC: 2834 Pharmaceutical Preparations